November 11, 2008 - Today at the annual scientific sessions of the American Heart Association in New Orleans the first U.S. clinical trial data on Medtronic's Melody transcatheter pulmonary valve...
November 10, 2008 - The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) is a three-day program dedicated to cell-based therapies for cardiovascular repair and...
October 15, 2008 - Cardiogenesis Corp. sponsored an educational symposium entitled "New Horizons in Cardiac Regenerative Medicine: Advancements in Revascularization & Stem Cell Therapy,"...
September 9, 2008 - CoreValve said today five clinical evaluation sites (two in New Zealand and three in Australia) have now completed their first series of proctored cases using the company’s...
September 3, 2008 – While a recent study into whether using unselected and selected bone-marrow derived cells can help with regeneration of heart tissue did not lead to significant improvement of...
August 28, 2008 - CoreValve said today an Australia/New Zealand-focused clinical evaluation of its proprietary percutaneous ReValving System, which features a porcine pericardium valve mounted in...
August 18, 2008 - Atritech Inc. today said it filed its pre-market approval application (PMA) with the FDA for its WATCHMAN Left Atrial Appendage (LAA) Closure Technology, which contains the...
July 29, 2008 - For several years, doctors have known that certain stem cells migrate to the heart after a heart attack, but exactly how they get there and what purpose they serve remained...
A new cardiac treatment facility that couples the benefits of interventional cardiology with cardiothoracic surgery for critically ill newborns, children and adults has opened at Rush University...
Toshiba America Medical Systems’ Infinix Hybrid cardiovascular X-ray imaging system will be featured in three live cases during the International Symposium on the Hybrid Approach to Congenital Heart...
June 8, 2008 - A new study about how shear stress improves adult stem cell attachment to vascular surfaces moves researchers closer to the development of a unique tissue-engineered stem cell...
April 22, 2008 - A new type of medication based on raising high-density lipoproteins (HDL), can lead to an improvement in the aortic valve narrowing, reported study results published on-line in...
April 15, 2008 - Researchers at the University of North Carolina at Chapel Hill's School of Medicine have shown some heart cells in response to one signal will act, while others lie in wait,...
April 15, 2008 - Physician scientists at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital have begun the world's first clinical trial to treat heart attack patients with a special...
April 14, 2008 - ESTECH will showcase its new CG LiV Kits, designed to enable mitral and aortic valve procedures, at the American Association for Thoracic Surgery 88th Annual Meeting in San Diego...
March 5, 2008 - Edwards Lifesciences Corp. reported that the first three human implants of the next-generation Edwards transcatheter aortic heart valve were performed at St. Paul's Hospital in...
February 11, 2008 – A new minimally invasive vascular occlusion device designed to close a patent ductus arteriosus (PDA) received European CE Mark approval.
February 8, 2008 - CryoLife Inc. received 510(k) clearance from the FDA for its CryoValve SG pulmonary human heart valve processed with the company’s proprietary SynerGraft technology, providing a...
February 7, 2008 - A Northwestern University Feinberg School of Medicine researcher has launched the first U.S. trial in which a purified form of subjects' own adult stem cells is transplanted...
January 30, 2008 - Aporo Biomedical signed an exclusive global licensing agreement with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP), enabling Aporo to offer...
January 14, 2008 - Scientists from the University of Minnesota Center for Cardiovascular Repair created a beating heart in the laboratory, according to research published in the online January 13...
January 7, 2008 - Cardica Inc. received nearly $2 million in payments from Cook Medical (Cook) for reaching milestones pursuant to its development agreements with Cook, including a vascular...
January 7, 2008 - Osiris Therapeutics Inc. has reclaimed sole worldwide rights to cardiovascular indications for Prochymal and terminated its development and commercialization agreement with...
December 27, 2007 - Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents to clear coronary artery blockages are among the top...
December 18, 2007 - ATS Medical Inc. today announced it has received FDA clearance for the ATS Open Pivot AP360 Mechanical Heart Valve designed to maximize hemodynamic performance with a new supra...
December 11, 2007 - ValveXchange, developer of a next-generation replacement heart valve technology, won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 Conference...
November 14, 2007 - The Heart Center at Nationwide Children’s Hospital performed the first procedure in the first hybrid congenital cardiac operating suite in the U.S., a facility designed...
November 7, 2007 – Injecting patients’ own stem cells – ones that exist in skeletal muscle – directly into the heart with a three-dimensional guided catheter is feasible, safe and might be...
November 7, 2007 - Patients’ own stem cells injected into their hearts after treatment for an ST elevation heart attack improved their hearts’ improved pumping ability, researchers reported during...
October 9, 2007 - W. L. Gore & Associates (Gore) announced that the FDA granted approval for the use of GORE HELEX Septal Occluder with a modified catheter delivery system indicated for the...
September 27, 2007 - Sutura Inc., a developer of minimally invasive vascular suturing devices, announced today that the first patient to receive a SuperStitch EL to close a Patent Foramen Ovale (...
September 13, 2007 - Millennium Research Group (MRG) conducted a detailed analysis of the stem cell therapy market in its "U.S. Markets for Stem Cell Therapies 2007" report, which shows while the...
September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and...
August 28, 2007 - Human embryonic stem cell (hESC)-derived cardiomyocytes improve heart function when transplanted after myocardial infarction, according to a study published in Nature...
July 20, 2007 – Oraganogenesis Inc. announced that it has received regulatory approval in Canada and Europe for BioSTAR, a device that incorporates a bioresorbable collagen scaffold used to treat...
June 20, 2007 —Robotic surgical technology available at Cedars-Sinai Medical Center avoids long-term use of blood thinners and problems such as infection by repairing the mitral valve instead of...
June 19, 2007 – Cardica Inc. and Cook Medical today announced that they have entered into an agreement to develop and commercialize a specialized device designed to close the patent foramen ovale...
June 11, 2007 — Cardio BioSciences and Mayo Clinic announced today that they have entered into a collaborative agreement related to the licensing of Mayo Clinic research, know-how and intellectual...
May 15, 2007 — Edwards Lifesciences Corp. announced last week that its subsidiary, Edwards Lifesciences PVT, Inc., has filed a patent infringement lawsuit against CoreValve Inc., of Irvine, Calif...
May 7, 2007 — Australia's adult stem cell company, Mesoblast Limited, has announced that the FDA has cleared the Investigational New Drug Submission (IND) of its U.S.-based sister company,...
April 24, 2007 — NMT Medical Inc. has announced it has received conditional approval from the FDA to its revised study hypothesis and statistical plan in the CLOSURE I patent foramen ovale (PFO)/...
April 18, 2007 — Associated Press reports that on Tuesday U.S. marshals and FDA investigators began seizing heart valves and other implantable medical devices made from cow and pig tissue by a New...
Dr. Nabil Dib, M.D., M.Sc., director of Cardiovascular Cell Therapy at University of California San Diego, reported how 23 patients in an FDA trial were safely transformed from advanced heart...
March 29, 2007 — At the ACC this week Dr. Nabil Dib, M.D., M.Sc., director of Cardiovascular Cell Therapy at University of California San Diego, reported how 23 patients in an FDA trial were...
March 22, 2007 — Evalve, Inc., a privately held medical device company, has announced the FDA has approved a registry of up to 70 patients who are at high risk of mortality from surgical treatment...
Feb. 7, 2007 — A first ever human procedure in Madrid took place this week in which a heart failure patient received adult stem cells removed from his own adipose (fat) tissue by liposuction. The...
The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to...
In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief...
CoreValve announced that its patented ReValving System, consisting of a 18F delivery catheter, was used to percutaneously implant its proprietary porcine pericardial-tissue bioprosthesis over the...
A test designed to measure the durability of CoreValve’s ReValving device reached 200 million cycles, the company has reported. CoreValve’s chairman, CEO and founder, Dr. Jacques Seguin, says...
A new procedure that delivers and places or repairs a heart valve through a catheter could soon become an alternative to open heart surgery for extremely high-risk patients.
